CA
NZ
UK
AU
IND
US
HeartBeam said on October 5, 2026 that the FDA granted Breakthrough Device Designation to the HeartBeam System as a tool for assessing potential heart attacks at home. Its 3D ECG captures the heart's electrical signals from three non-coplanar dimensions, letting physicians review ECG information …
Aldeyra Therapeutics shares sank on Monday, Oct. 5, while the Nasdaq Composite set a record, and no company-specific catalyst was found to explain the decline.
Alector shares surged on Monday, Oct. 5, after the biotech licensed its early-stage Parkinson's and neurodegeneration program to Roche's Genentech for $100 million upfront and up to $1.17 billion in milestones.
Ginkgo Bioworks shares surged again on Monday, extending a run that began with its AI drug-discoveryPartnershipwith Eli Lilly, though no new company announcement was found for the day.
Emergent BioSolutions shares surged on Monday as traders bid up biodefense names after reports of a suspected plague case at a Russian research institute, a case that has not been confirmed.
SeaStar Medical shares sank sharply on Monday, Oct. 5, even as the Nasdaq Composite closed at a record, and no company announcement was found to explain the drop.
Karyopharm Therapeutics shares tumbled on Monday, Oct. 5, as the Nasdaq Composite hit a record, but no company news was found to account for the slide.
Novavax shares surged on Monday, Oct. 5, as reports of a suspected plague case at a Russian research institute, which has not been confirmed, sent traders intoVaccineand biodefense stocks.
PacBio shares surged on Monday, Oct. 5, after EpiSign and Geneyx Genomex announced a rare-disease partnership built on data from PacBio's HiFi sequencing technology.
Vaxcyte shares soared on Monday, Oct. 5, after its VAX-31 pneumococcal vaccine met all of its main goals in a pivotal trial, and Guggenheim called the result "a major win."
Please wait processing your request...